Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
102 participants
OBSERVATIONAL
2023-10-03
2024-07-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Air Optix® Night and Day® Aqua Continuous Wear
NCT05992675
Air Optix® Night and Day® Aqua Therapeutic Wear
NCT05956535
Air Optix Night and Day Aqua (AONDA) Retrospective Study 1
NCT05790928
Air Optix Daily Wear Contact Lenses
NCT05827224
Air Optix Extended Wear Contact Lenses
NCT05886881
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The anticipated duration of the study is approximately 6 months.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
AONDA contact lenses
Lotrafilcon A contact lenses worn daily and removed at night for cleaning and disinfection as instructed by the eye care professional
Lotrafilcon A contact lenses
CE-marked silicone hydrogel contact lenses for daily wear use
PV2 contact lenses
Balafilcon A contact lenses worn daily and removed at night for cleaning and disinfection as instructed by the eye care professional
Balafilcon A contact lenses
CE-marked silicone hydrogel contact lenses for daily wear use
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lotrafilcon A contact lenses
CE-marked silicone hydrogel contact lenses for daily wear use
Balafilcon A contact lenses
CE-marked silicone hydrogel contact lenses for daily wear use
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* At the time of the 1-year visit, subject was prescribed and wearing AONDA contact lenses or PV2 contact lenses in both eyes in a daily wear modality for at least approximately 1 year without changing wear modality
* Baseline and 1-year visit charts available
Exclusion Criteria
* Use of systemic or ocular medications contraindicating regular contact lens wear at Baseline
* History of refractive surgery or irregular cornea
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Alcon Research
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Clinical Trial Lead, CRD Vision Care
Role: STUDY_DIRECTOR
Alcon Research, LLC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Contact Alcon Call Center for Trial Locations
Fort Worth, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CLD265-N002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.